Ranoux Claude Form 5 INVO Bioscience / Claude Ranoux ownership change

SEC Form 5

FORM 5

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

ANNUAL STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:	3235-0362
Estimated average burden
hours per response:	1.0

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Form 3 Holdings Reported.

X

Form 4 Transactions Reported.

1. Name and Address of Reporting Person^*

Ranoux Claude

(Last) (First) (Middle)

8 CHESTNUT STREET

(Street)

WINCHESTER MA 01890

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
INVO Bioscience, Inc. [ IVOB ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
X	Officer (give title below)		Other (specify below)
President

3. Statement for Issuer's Fiscal Year Ended (Month/Day/Year)
12/31/2010

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)	4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned at end of Issuer's Fiscal Year (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
				Amount	(A) or (D)	Price
INVO Bioscience Common Stock (Free trading)	01/05/2010		D4	10,000	D	$0.19	25,481,473	D
INVO Bioscience Common Stock (Free trading)	01/06/2010		D4	9,222	D	$0.18	25,472,251	D
INVO Bioscience Common Stock (Free trading)	06/25/2010		D4	10,000	D	$0.1	25,462,251	D
INVO Bioscience Common Stock (Free trading)	06/28/2010		D4	10,000	D	$0.1	25,452,251	D
INVO Bioscience Common Stock (Free trading)	07/01/2010		D4	11,000	D	$0.085	25,441,251	D
INVO Bioscience Common Stock (Free trading)	07/02/2010		D4	30,000	D	$0.08	25,411,251	D
INVO Bioscience Common Stock (Free trading)	07/02/2010		D4	500	D	$0.085	25,410,751	D
INVO Bioscience Common Stock (Free trading)	08/02/2010		D4	5,000	D	$0.078	25,405,751	D
INVO Bioscience Common Stock (Free trading)	08/02/2010		D4	5,500	D	$0.077	25,400,251	D
INVO Bioscience Common Stock (Free trading)	08/03/2010		D4	1,224	D	$0.083	25,399,027	D
INVO Bioscience Common Stock (Free trading)	08/03/2010		D4	10,000	D	$0.08	25,389,027	D
INVO Bioscience Common Stock (Free trading)	08/05/2010		D4	600	D	$0.066	25,388,427	D
INVO Bioscience Common Stock (Free trading)	08/06/2010		D4	4,560	D	$0.075	25,383,867	D
INVO Bioscience Common Stock (Free trading)	08/10/2010		D4	5,000	D	$0.075	25,378,867	D
INVO Bioscience Common Stock (Free trading)	08/10/2010		D4	15,000	D	$0.08	25,363,867	D
INVO Bioscience Common Stock (Free trading)	08/11/2010		D4	10,000	D	$0.08	25,353,867	D
INVO Bioscience Common Stock (Free trading)	09/14/2010		D4	10,000	D	$0.04	25,343,867	D
INVO Bioscience Common Stock (Free trading)	09/16/2010		D4	5,000	D	$0.04	25,338,867	D
INVO Bioscience Common Stock (Free trading)	09/16/2010		D4	5,000	D	$0.045	25,333,867	D
INVO Bioscience Common Stock (Free trading)	09/17/2010		D4	500	D	$0.045	25,333,367	D
INVO Bioscience Common Stock (Free trading)	09/21/2010		D4	10,000	D	$0.035	25,323,367	D
INVO Bioscience Common Stock (Free trading)	09/21/2010		D4	10,000	D	$0.045	25,313,367	D
INVO Bioscience Common Stock (Free trading)	12/13/2010		D4	10,000	D	$0.045	25,303,367	D
INVO Bioscience Common Stock (Free trading)	12/13/2010		D4	10,000	D	$0.042	25,293,367	D
INVO Bioscience Common Stock (Free trading)	12/17/2010		D4	10,000	D	$0.048	25,283,367	D
INVO Bioscience Common Stock (Free trading)	12/17/2010		D4	10,000	D	$0.042	25,273,367	D
INVO Bioscience Common Stock (Free trading)	12/22/2010		D4	10,000	D	$0.04	25,263,367	D
INVO Bioscience Common Stock (Free trading)	12/22/2010		D4	10,000	D	$0.039	25,253,367	D
INVO Bioscience Common Stock (Free trading)	12/27/2010		D4	10,000	D	$0.04	25,243,367	D
INVO Bioscience Common Stock (Free trading)	12/27/2010		A4	650,000	A	$0.01	25,893,367	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)	5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
					(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

Remarks:

During year 2010, I traded my securities on the public market using Morgan Stanley Smith Barney, as my agent, my account number is 486-175757-0-161. I used Morgan Stanley, until 03/29/2012; financial difficulties did not allow INVO Bioscience to pay for the financial audits. From March 29, 2012 until 2017, the stock of INVO Bioscience was traded in the Pink Sheet. On December 27, 2010, I acquired 650,000 restricted securities. The total of restricted shares was 24,661,473(2008)+ 650,000 = 25,311,473 restricted securities. In 2010, I sold 307,606 free trading shares. On 12/31/2010 the total of free trading shares left was 830,000 (2009) - 307,606 = 522,394 free trading shares. In December 31, 2010, the total of securities I owned was 25,491,473 (2009) + 650,000 - 307,606 = 25,833,867 shares

	/s/ Claude Ranoux	07/26/2017
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.